Drugs / ASP1240
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01565681 | Jan → Dec 2009 | — | Astellas Pharma Global Development, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP1240 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01565681 ↗ |
| Route | Intravenous | “single intravenous dose” NCT01565681 ↗ |